Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry labeled v3.6.4 was added to the Study Record History, indicating an update to the page's version history. This reflects an internal update rather than changes to study content or user-facing elements.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new revision entry v3.6.3 was added to the Record History and the previous v3.6.2 entry was removed, updating the page's version history.SummaryDifference0.1%

- Check29 days agoChange DetectedA new revision entry v3.6.2 was added to the study history. The v3.6.0 entry was removed, updating the visible revision history to reflect the latest version.SummaryDifference0.1%

- Check43 days agoChange DetectedThe record history now shows explicit Last verified and Last known status were fields and lists the current revision as v3.6.0, replacing the previous revision v3.5.5.SummaryDifference2%

- Check51 days agoChange DetectedA new revision entry v3.5.5 was added, replacing the previous revision v3.5.4. This is a platform update and does not modify the study record data.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.5.4 has been added to the record history, replacing the previous v3.5.3. This reflects a minor update to the historical record rather than changes to the study data.SummaryDifference0.1%

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.